Company Profile
Aptevo Therapeutics Stock Price, News & Analysis
- Ticker:
- APVO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Aptevo Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
4.63 USD (-2.53%)
Close
Last updated: June 23, 2026 at 00:00
5.77M USD
Market cap
Why the stock is moving
APVO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Aptevo Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Aptevo Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Aptevo Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Aptevo Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer
Source: Aptevo Therapeutics
- 02
- 03
- 04
Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update
Source: Aptevo Therapeutics
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Aptevo Therapeutics (APVO)?
Aptevo Therapeutics (APVO) most recently closed at 4.63 USD, a -2.53% move versus the previous session.
What is the market cap of Aptevo Therapeutics (APVO)?
Aptevo Therapeutics currently has a market capitalization of 5.77M USD on BioPharmSignal.
What does Aptevo Therapeutics do?
Aptevo Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is APVO stock listed?
Aptevo Therapeutics (APVO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Aptevo Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Aptevo?
Aptevo Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Aptevo Therapeutics targeting with Aptevo?
Aptevo Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Aptevo Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.